Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX)
CUSIP: 92243G108
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 145,782,011
- Total 13F shares
- 147,479,114
- Share change
- -490,442
- Total reported value
- $4,794,596,759
- Put/Call ratio
- 72%
- Price per share
- $32.51
- Number of holders
- 292
- Value change
- -$48,097,035
- Number of buys
- 181
- Number of sells
- 147
Quarterly Holders Quick Answers
What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92243G108:
Top shareholders of PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
8.1%
|
11,765,481
|
$815,865,294 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
8.6%
|
12,512,234
|
$472,461,968 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
8.4%
|
12,189,149
|
$460,262,266 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.3%
|
12,043,805
|
$454,774,078 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.6%
from 13D/G
|
10,579,477
|
$399,481,054 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.4%
|
6,416,930
|
$242,303,276 | — | 31 Mar 2025 | |
| Capital Research Global Investors |
13F
|
Company |
4.2%
|
6,110,108
|
$230,717,678 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
4,407,683
|
$166,434,110 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.4%
|
3,542,007
|
$133,747,000 | — | 31 Mar 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
2.2%
|
3,200,000
|
$120,832,000 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.1%
|
3,089,032
|
$116,641,866 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
2,869,054
|
$108,359,095 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.9%
|
2,702,691
|
$102,054,000 | — | 31 Mar 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.5%
|
2,155,137
|
$81,377,973 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
1,900,179
|
$71,750,773 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.2%
|
1,704,211
|
$64,351,007 | — | 31 Mar 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
1.2%
|
1,696,481
|
$64,059,123 | — | 31 Mar 2025 | |
| Commodore Capital LP |
13F
|
Company |
1.1%
|
1,650,000
|
$62,304,000 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.91%
|
1,333,382
|
$50,348,504 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.86%
|
1,255,827
|
$47,420,027 | — | 31 Mar 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.84%
|
1,220,455
|
$46,084,376 | — | 31 Mar 2025 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
0.83%
|
1,208,093
|
$45,617,592 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.82%
|
1,197,688
|
$45,224,699 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.79%
|
1,147,302
|
$43,322,123 | — | 31 Mar 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.77%
|
1,125,720
|
$42,507,186 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
1,122,956
|
$42,402,819 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.72%
|
1,050,678
|
$42,168,645 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.76%
|
1,111,777
|
$41,980,700 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.74%
|
1,082,473
|
$40,874,180 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.74%
|
1,080,396
|
$40,795,753 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.73%
|
1,060,863
|
$40,058,187 | — | 31 Mar 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.69%
|
1,000,000
|
$37,760,000 | — | 31 Mar 2025 | |
| Novo Holdings A/S |
13F
|
Company |
0.63%
|
915,000
|
$34,550,400 | — | 31 Mar 2025 | |
| NORGES BANK |
13F
|
Company |
0.62%
|
899,842
|
$33,978,034 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.6%
|
867,891
|
$32,771,564 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.54%
|
790,812
|
$29,861,061 | — | 31 Mar 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.52%
|
751,614
|
$28,380,945 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
0.51%
|
750,000
|
$28,320,000 | — | 31 Mar 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.51%
|
744,160
|
$28,099,482 | — | 31 Mar 2025 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.49%
|
710,734
|
$26,837,316 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.48%
|
706,567
|
$26,679,970 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.47%
|
678,581
|
$25,613,396 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.44%
|
640,885
|
$24,199,818 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.43%
|
621,079
|
$23,451,944 | — | 31 Mar 2025 | |
| Jeff Fairman |
3/4/5
|
VP, Research |
—
mixed-class rows
|
369,054
mixed-class rows
|
$22,935,618 | — | 30 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.42%
|
606,951
|
$22,918,529 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.4%
|
587,054
|
$22,167,189 | — | 31 Mar 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.39%
|
570,258
|
$21,532,941 | — | 31 Mar 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.38%
|
557,794
|
$21,061,000 | — | 31 Mar 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.38%
|
557,070
|
$21,034,963 | — | 31 Mar 2025 |
Institutional Holders of Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) as of Q2 2025
As of 30 Jun 2025,
Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) was held by
292 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
147,479,114 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, FMR LLC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital Research Global Investors, and Paradigm Biocapital Advisors LP.
This page lists
294
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
302
Q2 2025 holders
292
Holder diff
-10
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.